Marshall Wace North America’s Outlook Therapeutics OTLK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,246
Closed -$100K 1811
2018
Q4
$100K Sell
1,246
-390
-24% -$31.3K ﹤0.01% 1085
2018
Q3
$257K Hold
1,636
﹤0.01% 812
2018
Q2
$220K Hold
1,636
﹤0.01% 1249
2018
Q1
$233K Hold
1,636
﹤0.01% 1310
2017
Q4
$340K Hold
1,636
﹤0.01% 1217
2017
Q3
$262K Hold
1,636
﹤0.01% 1148
2017
Q2
$262K Hold
1,636
﹤0.01% 1179
2017
Q1
$785K Buy
+1,636
New +$785K 0.01% 739